Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Leukemia|April 2, 2020
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemiaTobias Herold, Maja Rothenberg-Thurley, Victoria V Grunwald, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML IntergroupThomas Büchner, Richard F Schlenk, Markus Schaich, et al.Annals of Hematology|October 24, 2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative GroupEva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, et al.Blood|December 31, 2011
Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor geneShuchi Agrawal-Singh, Fabienne Isken, Konstantin Agelopoulos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trialHubert Serve, Utz Krug, Ruth Wagner, et al.Blood|June 12, 2016
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemiaKlaus H Metzeler, Tobias Herold, Maja Rothenberg-Thurley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemiaFriederike Pastore, Annika Dufour, Tobias Benthaus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trialChristoph Röllig, Martin Bornhäuser, Michael Kramer, et al.Communications Medicine|May 17, 2023
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profilesJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.Haematologica|June 16, 2022
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, et al.Pageof 8